Exelon (NASDAQ:EXC) Releases Quarterly Earnings Results

Exelon (NASDAQ:EXC) released its quarterly earnings data on Tuesday. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.69 by $0.17, Zacks reports. Exelon had a net margin of 11.16% and a return on equity of 9.85%. The firm had revenue of $6.71 billion for the quarter, compared to the consensus estimate of $6.40 billion. Exelon updated its FY 2025 guidance to 2.640-2.740 EPS.

Exelon Stock Down 0.5%

EXC stock opened at $46.15 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.95 and a debt-to-equity ratio of 1.66. The firm has a market capitalization of $46.61 billion, a PE ratio of 17.55, a PEG ratio of 2.93 and a beta of 0.40. Exelon has a twelve month low of $35.94 and a twelve month high of $48.51. The stock has a 50-day simple moving average of $45.32 and a two-hundred day simple moving average of $44.53.

Exelon Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Monday, November 10th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend is Monday, November 10th. Exelon’s payout ratio is presently 60.84%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Chapman Financial Group LLC purchased a new position in shares of Exelon during the second quarter worth about $62,000. HUB Investment Partners LLC purchased a new stake in Exelon in the second quarter worth approximately $227,000. Caxton Associates LLP purchased a new stake in Exelon in the first quarter worth approximately $286,000. LMR Partners LLP boosted its stake in Exelon by 43.7% in the second quarter. LMR Partners LLP now owns 6,960 shares of the company’s stock worth $302,000 after buying an additional 2,115 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in Exelon by 59.3% in the second quarter. Geneos Wealth Management Inc. now owns 7,279 shares of the company’s stock worth $316,000 after buying an additional 2,709 shares in the last quarter. Hedge funds and other institutional investors own 80.92% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on EXC shares. BTIG Research began coverage on shares of Exelon in a report on Tuesday, October 21st. They issued a “neutral” rating on the stock. Evercore ISI started coverage on shares of Exelon in a research report on Monday, October 6th. They issued an “outperform” rating and a $57.00 target price for the company. UBS Group upped their price objective on shares of Exelon from $48.00 to $50.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. KeyCorp upped their price objective on shares of Exelon from $37.00 to $42.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 15th. Finally, Morgan Stanley upped their price objective on shares of Exelon from $49.00 to $53.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $50.55.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.